• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

KinCon:基于细胞的全长激酶构象记录。

KinCon: Cell-based recording of full-length kinase conformations.

机构信息

Institute of Biochemistry and Center for Molecular Biosciences, University of Innsbruck, Innsbruck, Austria.

出版信息

IUBMB Life. 2020 Jun;72(6):1168-1174. doi: 10.1002/iub.2241. Epub 2020 Feb 6.

DOI:10.1002/iub.2241
PMID:32027084
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7318358/
Abstract

The spectrum of kinase alterations displays distinct functional characteristics and requires kinase mutation-oriented strategies for therapeutic interference. Besides phosphotransferase activity, protein abundance, and intermolecular interactions, particular patient-mutations promote pathological kinase conformations. Despite major advances in identifying lead molecules targeting clinically relevant oncokinase functions, still many kinases are neglected and not part of drug discovery efforts. One explanation is attributed to challenges in tracking kinase activities. Chemical probes are needed to functionally annotate kinase functions, whose activities may not always depend on catalyzing phospho-transfer. Such non-catalytic kinase functions are related to transitions of full-length kinase conformations. Recent findings underline that cell-based reporter systems can be adapted to record conformation changes of kinases. Here, we discuss the possible applications of an extendable kinase conformation (KinCon) reporter toolbox for live-cell recording of kinase states. KinCon is a genetically encoded bioluminescence-based biosensor platform, which can be subjected for measurements of conformation dynamics of mutated kinases upon small molecule inhibitor exposure. We hypothesize that such biosensors can be utilized to delineate the molecular modus operandi for kinase and pseudokinase regulation. This should pave the path for full-length kinase-targeted drug discovery efforts aiming to identify single and combinatory kinase inhibitor therapies with increased specificity and efficacy.

摘要

激酶改变的谱显示出独特的功能特征,需要针对激酶突变的策略进行治疗干预。除了磷酸转移酶活性、蛋白质丰度和分子间相互作用外,特定的患者突变会促进病理性激酶构象。尽管在确定针对临床相关致癌激酶功能的先导分子方面取得了重大进展,但仍有许多激酶被忽视,未被纳入药物发现工作中。一种解释归因于跟踪激酶活性的挑战。需要化学探针来对激酶功能进行功能注释,其活性并不总是依赖于催化磷酸转移。这种非催化激酶功能与全长激酶构象的转变有关。最近的发现强调,基于细胞的报告系统可以被改编来记录激酶构象的变化。在这里,我们讨论了可扩展激酶构象(KinCon)报告工具包在活细胞记录激酶状态中的可能应用。KinCon 是一种基于遗传编码的生物发光生物传感器平台,可用于测量小分子抑制剂暴露后突变激酶的构象动力学。我们假设,这种生物传感器可用于描绘激酶和拟激酶调节的分子作用模式。这将为全长激酶靶向药物发现工作铺平道路,旨在确定具有更高特异性和疗效的单一和组合激酶抑制剂治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f14/7318358/6a88f292060a/IUB-72-1168-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f14/7318358/29dd990f922d/IUB-72-1168-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f14/7318358/16b08d481829/IUB-72-1168-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f14/7318358/6a88f292060a/IUB-72-1168-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f14/7318358/29dd990f922d/IUB-72-1168-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f14/7318358/16b08d481829/IUB-72-1168-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f14/7318358/6a88f292060a/IUB-72-1168-g003.jpg

相似文献

1
KinCon: Cell-based recording of full-length kinase conformations.KinCon:基于细胞的全长激酶构象记录。
IUBMB Life. 2020 Jun;72(6):1168-1174. doi: 10.1002/iub.2241. Epub 2020 Feb 6.
2
Mutation-oriented profiling of autoinhibitory kinase conformations predicts RAF inhibitor efficacies.靶向突变的自抑制激酶构象分析预测 RAF 抑制剂的疗效。
Proc Natl Acad Sci U S A. 2020 Dec 8;117(49):31105-31113. doi: 10.1073/pnas.2012150117. Epub 2020 Nov 23.
3
Tracking mutation and drug-driven alterations of oncokinase conformations.追踪癌激酶构象的突变及药物驱动的改变。
Memo. 2022 Jun;15(2):137-142. doi: 10.1007/s12254-021-00790-6. Epub 2022 Jan 21.
4
Allosteric Kinase Inhibitors Reshape MEK1 Kinase Activity Conformations in Cells and In Silico.变构激酶抑制剂重塑细胞内和计算机模拟中的MEK1激酶活性构象。
Biomolecules. 2021 Mar 30;11(4):518. doi: 10.3390/biom11040518.
5
Impact of protein and small molecule interactions on kinase conformations.蛋白质与小分子相互作用对激酶构象的影响。
Elife. 2024 Aug 1;13:RP94755. doi: 10.7554/eLife.94755.
6
Tracking and blocking interdependencies of cellular BRAF-MEK oncokinase activities.追踪和阻断细胞BRAF-MEK癌激酶活性的相互依赖性。
PNAS Nexus. 2023 Jun 5;2(6):pgad185. doi: 10.1093/pnasnexus/pgad185. eCollection 2023 Jun.
7
Mutation that blocks ATP binding creates a pseudokinase stabilizing the scaffolding function of kinase suppressor of Ras, CRAF and BRAF.突变阻断了 ATP 的结合,从而产生了一个假激酶,稳定了 Ras、 CRAF 和 BRAF 激酶抑制剂的支架功能。
Proc Natl Acad Sci U S A. 2011 Apr 12;108(15):6067-72. doi: 10.1073/pnas.1102554108. Epub 2011 Mar 25.
8
MEK drives BRAF activation through allosteric control of KSR proteins.MEK 通过变构控制 KSR 蛋白驱动 BRAF 的激活。
Nature. 2018 Feb 22;554(7693):549-553. doi: 10.1038/nature25478. Epub 2018 Feb 12.
9
Conformational control and regulation of the pseudokinase KSR via small molecule binding interactions.通过小分子结合相互作用对拟激酶 KSR 的构象控制和调节。
Methods Enzymol. 2022;667:365-402. doi: 10.1016/bs.mie.2022.03.039. Epub 2022 Apr 25.
10
Fluorescent biosensors - probing protein kinase function in cancer and drug discovery.荧光生物传感器——探索癌症中蛋白激酶功能与药物研发
Biochim Biophys Acta. 2013 Jul;1834(7):1387-95. doi: 10.1016/j.bbapap.2013.01.025. Epub 2013 Feb 1.

引用本文的文献

1
Impact of protein and small molecule interactions on kinase conformations.蛋白质与小分子相互作用对激酶构象的影响。
Elife. 2024 Aug 1;13:RP94755. doi: 10.7554/eLife.94755.
2
Resistor: An algorithm for predicting resistance mutations via Pareto optimization over multistate protein design and mutational signatures.电阻器:一种通过多态蛋白质设计和突变特征的 Pareto 优化来预测耐药突变的算法。
Cell Syst. 2022 Oct 19;13(10):830-843.e3. doi: 10.1016/j.cels.2022.09.003.
3
Tracking mutation and drug-driven alterations of oncokinase conformations.

本文引用的文献

1
Allosteric Small-Molecule Serine/Threonine Kinase Inhibitors.变构小分子丝氨酸/苏氨酸激酶抑制剂。
Adv Exp Med Biol. 2019;1163:253-278. doi: 10.1007/978-981-13-8719-7_11.
2
BRAF inhibitors promote intermediate BRAF(V600E) conformations and binary interactions with activated RAS.BRAF 抑制剂促进中间态 BRAF(V600E)构象和与激活的 RAS 的二元相互作用。
Sci Adv. 2019 Aug 14;5(8):eaav8463. doi: 10.1126/sciadv.aav8463. eCollection 2019 Aug.
3
Emerging concepts in pseudoenzyme classification, evolution, and signaling.伪酶分类、进化和信号转导的新观点。
追踪癌激酶构象的突变及药物驱动的改变。
Memo. 2022 Jun;15(2):137-142. doi: 10.1007/s12254-021-00790-6. Epub 2022 Jan 21.
4
A human kinase yeast array for the identification of kinases modulating phosphorylation-dependent protein-protein interactions.一种用于鉴定调节磷酸化依赖性蛋白-蛋白相互作用的激酶的人类激酶酵母阵列。
Mol Syst Biol. 2022 Mar;18(3):e10820. doi: 10.15252/msb.202110820.
5
mTORC2 controls the activity of PKC and Akt by phosphorylating a conserved TOR interaction motif.mTORC2 通过磷酸化一个保守的 TOR 相互作用基序来控制 PKC 和 Akt 的活性。
Sci Signal. 2021 Apr 13;14(678):eabe4509. doi: 10.1126/scisignal.abe4509.
6
Allosteric Kinase Inhibitors Reshape MEK1 Kinase Activity Conformations in Cells and In Silico.变构激酶抑制剂重塑细胞内和计算机模拟中的MEK1激酶活性构象。
Biomolecules. 2021 Mar 30;11(4):518. doi: 10.3390/biom11040518.
7
Mutation-oriented profiling of autoinhibitory kinase conformations predicts RAF inhibitor efficacies.靶向突变的自抑制激酶构象分析预测 RAF 抑制剂的疗效。
Proc Natl Acad Sci U S A. 2020 Dec 8;117(49):31105-31113. doi: 10.1073/pnas.2012150117. Epub 2020 Nov 23.
8
Cataloguing the dead: breathing new life into pseudokinase research.为死者立传:为假激酶研究注入新活力。
FEBS J. 2020 Oct;287(19):4150-4169. doi: 10.1111/febs.15246. Epub 2020 Mar 10.
Sci Signal. 2019 Aug 13;12(594):eaat9797. doi: 10.1126/scisignal.aat9797.
4
Properties of FDA-approved small molecule protein kinase inhibitors.已批准用于临床的小分子蛋白激酶抑制剂的特性。
Pharmacol Res. 2019 Jun;144:19-50. doi: 10.1016/j.phrs.2019.03.006. Epub 2019 Mar 13.
5
Prospects for pharmacological targeting of pseudokinases.针对假激酶的药理学靶向的前景。
Nat Rev Drug Discov. 2019 Jul;18(7):501-526. doi: 10.1038/s41573-019-0018-3.
6
Covalent inhibitors of EGFR family protein kinases induce degradation of human Tribbles 2 (TRIB2) pseudokinase in cancer cells.共价型 EGFR 家族蛋白激酶抑制剂可诱导人 Tribbles 2(TRIB2)假激酶在癌细胞中的降解。
Sci Signal. 2018 Sep 25;11(549):eaat7951. doi: 10.1126/scisignal.aat7951.
7
Targeting kinases with precision.精准靶向激酶。
Mol Cell Oncol. 2018 Apr 11;5(3):e1435183. doi: 10.1080/23723556.2018.1435183. eCollection 2018.
8
Kinase inhibitors: the road ahead.激酶抑制剂:前路漫漫。
Nat Rev Drug Discov. 2018 May;17(5):353-377. doi: 10.1038/nrd.2018.21. Epub 2018 Mar 16.
9
Kinase-targeted cancer therapies: progress, challenges and future directions.激酶靶向癌症疗法:进展、挑战与未来方向。
Mol Cancer. 2018 Feb 19;17(1):48. doi: 10.1186/s12943-018-0804-2.
10
Quantitative, Wide-Spectrum Kinase Profiling in Live Cells for Assessing the Effect of Cellular ATP on Target Engagement.在活细胞中进行定量、广谱激酶分析,以评估细胞 ATP 对靶标结合的影响。
Cell Chem Biol. 2018 Feb 15;25(2):206-214.e11. doi: 10.1016/j.chembiol.2017.10.010. Epub 2017 Nov 22.